glofitamab,Obinutuzumab 
roche
['glofitamab', 'lymphoma', 'pivotal', 'roche']
bispecific antibodies look to join a multitude of new treatment options in diffuse large b-cell lymphoma. how will roche/genentech s glofitamab fair given newly released data from the pivotal np30179 study? view this vlog #asco22 #oncology #glofitamab
Bringing remarkable clarity to life sciences’ and healthcare's most important decisions.